Newsroom
Market News
Both sides of the trade, grades and news round-ups. Click a headline to read it — the arrows walk the list.
Research
- Gevo: How the Bull and Bear Lists Compare
- Hub Group Draws a Bearish Lean From the Lists
- LGI Homes Sees the Argument Tilt Toward Split
- CEVA in Focus: The Bulls Have More to Work With
- Cohu and the Split Between 8 Bulls and 2 Bears
- MacroGenics Draws Both Sides as The Bulls Have More to Work With
- AxoGen Sees the Argument Tilt Toward Bullish
- The Bulls Have More to Work With for Duluth as the Counts Stack Up
- Precipio: More Bulls Than Bears in the Dossier
- What the Data Says For and Against Ames National Corporation (ATLO)
- TriMas Sets Up a 3-Point Bull Case Against a 5-Point Bear Case
- Progress Software Corporation (PRGS): The Bulls Have More to Work With on the Numbers, 8 Bullish Points to 2 Bearish
- BlackRock TCP Capital Sees the Argument Tilt Toward Bullish
- Oaktree Specialty Lending in Focus: An Evenly Argued Case
- BancFirst Has 6 Bulls and 3 Bears to Sort Through
- Plexus: The Bulls Have More to Work With After the Latest Review
- The Bears Have More to Work With for Atomera as the Counts Stack Up
- Trupanion: How the Bull and Bear Lists Compare
- Helen of Troy With The Bulls Have More to Work With and a Bear Case Still Standing
- What the Data Says For and Against Alpha and Omega Semiconductor (AOSL)
- Tower Semiconductor: Why the Case Still Cuts Both Ways
- Methanex and the Split Between 7 Bulls and 5 Bears
- What the Data Says For and Against Patterson-UTI Energy, Inc. (PTEN)
- Boxlight Draws a Split Lean From the Lists
- The Goodyear Tire & Rubber Trading History Meets a Split Fundamental Case
- The Bull and Bear Case for Rigel Pharmaceuticals, Inc. (RIGL): 8 Points Against 4
- TechTarget Looks Bearish by Count, Not by Certainty
- Smart Sand After the Filings: The Bulls Have More to Work With
- The Bulls Have More to Work With for Nova as the Counts Stack Up
- Gilat Satellite Networks Leaves Both Camps With Plenty to Point to
- Phibro Animal Health Sets Up an 8-Point Bull Case Against a 3-Point Bear Case
- 1st Source in the Numbers: The Bulls Have More to Work With
- The Bull and Bear Case for RADCOM Ltd. (RDCM): 3 Points Against 8
- Star Bulk Carriers Sees the Argument Tilt Toward Bullish
- Fate Therapeutics: Holds 34.0% above its 200-day average as FY2025 earnings fell 26.8% to -$136.32M
- SPS Commerce Leaves Both Camps With Plenty to Point to
- Trustmark in the Numbers: The Bulls Have More to Work With
- Agios Pharmaceuticals: Stronger Bull Case, but the Bear Case Stays
- Daktronics: An Evenly Argued Case After the Latest Review
- Kopin Looks Bullish by Count, Not by Certainty
Ask the market a question. Get a calculated answer.
The AI is not a chatbot bolted onto a document store. It calls the same analytics engine that powers every screen on this platform — so what comes back is a number it computed from raw history, with the command that produced it.
86,000+ instruments
Global equities, ETFs, funds, options, FX, commodities, crypto, economics, filings, transcripts and news — one normalised symbol universe with adjusted history.
A real analytics engine
Screening, backtesting, technicals, options analytics, correlations, seasonality and factor models — computed on demand from raw prices, never a stale cache.
It shows its working
Answers arrive with the charts, tables and tool calls behind them, so you can check the number instead of trusting a paraphrase.
Your own documents
Upload filings, decks and research. Ask across them and the answer cites the page it came from.
Agents and workflows
Multi-step research that runs the platform's tools for you — screen, pull the history, compute, compare, then write it up.
MCP, CLI and API
The same command catalogue from Claude, your own agent, a shell or your pipeline. The answer on screen is the answer your job gets at 4am.
You ask
“How does NVDA usually trade through earnings?”
It calls
→ ka.options_expected_move(NVDA)
It answers
NVDA has averaged a 9.2% absolute move on the day after earnings and closed higher 67% of the time. Two in three reactions land between −4.2% and +16.3% — the distribution is skewed right, not symmetric.
Every figure computed live from our own history — not scraped, not summarised.
Or start with